Alnylam Sweden AB
559086-6686ActiveLeading RNAi therapeutics company developing gene-silencing medicines.
Biopharmaceutical Companyalnylam.se
Yleiskatsaus
- 5–9
- Työntekijät
- 100–500milj SEK
- Liikevaihto
- 2016
- Perustettu
Kuvaus
Alnylam Pharmaceuticals is a leading global biopharmaceutical company dedicated to pioneering RNA interference (RNAi) therapeutics. They focus on developing an innovative class of medicines designed to treat diseases by silencing the specific genes responsible for causing them. This mechanism target...
Tunnisteet
B2BB2CTechnologyPharmaceuticalsHealthTech